Apyx Medical gains on higher Q2 revenue
** Apyx Medical's APYX.O shares up 18.8% at $4.99
** Company posts Q2 revenue of $13.6 mln, up 32%
** Reports Q2 loss of $0.03/shr vs loss of $0.16/shr a year
earlier
** Company reaffirms 2023 financial outlook
** APYX shares have more than doubled YTD
(Reporting by Rupali Chaudhary in Bengaluru)
((mailto:Rupali.chaudhary@thomsonreuters.com))
Recent news on Apyx Medical
See all newsBrief: Apyx Medical - Appoints Stavros Vizirgianakis As Executive Chairman Effective June 11, 2026
Brief: Apyx Medical Corporation Receives Expanded FDA 510(K) Clearance Adding Power Liposuction Capability To AYON Body Contouring System™
Apyx Medical Q1 revenue beats estimates, outlook raised
Preview: Weight-loss revolution sparks new appetite for aesthetics firms
Apyx Medical Q4 revenue beats on Surgical Aesthetics unit strength